Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ritu Gupta

Showing results (241-250 of 332) with videos related to

Pageof 34
Sort By:
Leukemia & Lymphoma|November 2, 2012
Angiopoietins as biomarker of disease activity and response to therapy in multiple myelomaArchana Bhaskar, Ritu Gupta, Sreenivas Vishnubhatla, et al.
Leukemia Research|December 22, 2018
Clinical impact of chromothriptic complex chromosomal rearrangements in newly diagnosed multiple myelomaGurvinder Kaur, Ritu Gupta, Nitin Mathur, et al.
Leukemia Research|August 9, 2021
Proposal and clinical application of molecular genetic risk scoring system, "MRplus", for BCR-ABL1 negative pediatric B-cell acute lymphoblastic leukemia- report from a single centreSanjeev Kumar Gupta, Sameer Bakhshi, Vineet Kumar Kamal, et al.
Cytometry. Part B, Clinical Cytometry|June 7, 2013
Increased coexpression of c-KIT and FLT3 receptors on myeloblasts: independent predictor of poor outcome in pediatric acute myeloid leukemiaSurender Kumar Sharawat, Ritu Gupta, Vinod Raina, et al.
American Journal of Clinical Pathology|November 1, 2022
Graded Depth of Response and Neoplastic Plasma Cell Index as Indicators of Survival Outcomes in Patients With Multiple Myeloma Following Autologous Stem Cell TransplantNupur Das, Meetu Dahiya, Ritu Gupta, et al.
Oncotarget|July 16, 2019
PARP-1 inhibitor modulate β-catenin signaling to enhance cisplatin sensitivity in cancer cervixMinakshi Mann, Sachin Kumar, Ashok Sharma, et al.
Oncotarget|August 16, 2019
Correction: PARP-1 inhibitor modulate β-catenin signaling to enhance cisplatin sensitivity in cancer cervixMinakshi Mann, Sachin Kumar, Shyam S Chauhan, et al.
Journal of the American Heart Association|March 26, 2013
Glycemic associations with endothelial function and biomarkers among 5 ethnic groups: the Multi-Ethnic Study of Atherosclerosis and the Mediators of Atherosclerosis in South Asians Living in America studiesAlka M Kanaya, Devon A Dobrosielski, Peter Ganz, et al.
Clinical Epigenetics|June 3, 2017
Genome-wide DNA methylation profiling integrated with gene expression profiling identifies <i>PAX9</i> as a novel prognostic marker in chronic lymphocytic leukemiaLata Rani, Nitin Mathur, Ritu Gupta, et al.
Current Pharmaceutical Design|May 27, 2024
Diagnosis of the Initial Stage of Hepatocellular Carcinoma: A ReviewKrishana Kumar Sharma, Mohd Mohsin, Piyush Mittal, et al.
Pageof 34

Showing results (241-250 of 332) with videos related to

Sort By:
Pageof 34
Leukemia & Lymphoma|November 2, 2012
Angiopoietins as biomarker of disease activity and response to therapy in multiple myelomaArchana Bhaskar, Ritu Gupta, Sreenivas Vishnubhatla, et al.
Leukemia Research|December 22, 2018
Clinical impact of chromothriptic complex chromosomal rearrangements in newly diagnosed multiple myelomaGurvinder Kaur, Ritu Gupta, Nitin Mathur, et al.
Leukemia Research|August 9, 2021
Proposal and clinical application of molecular genetic risk scoring system, "MRplus", for BCR-ABL1 negative pediatric B-cell acute lymphoblastic leukemia- report from a single centreSanjeev Kumar Gupta, Sameer Bakhshi, Vineet Kumar Kamal, et al.
Cytometry. Part B, Clinical Cytometry|June 7, 2013
Increased coexpression of c-KIT and FLT3 receptors on myeloblasts: independent predictor of poor outcome in pediatric acute myeloid leukemiaSurender Kumar Sharawat, Ritu Gupta, Vinod Raina, et al.
American Journal of Clinical Pathology|November 1, 2022
Graded Depth of Response and Neoplastic Plasma Cell Index as Indicators of Survival Outcomes in Patients With Multiple Myeloma Following Autologous Stem Cell TransplantNupur Das, Meetu Dahiya, Ritu Gupta, et al.
Oncotarget|July 16, 2019
PARP-1 inhibitor modulate β-catenin signaling to enhance cisplatin sensitivity in cancer cervixMinakshi Mann, Sachin Kumar, Ashok Sharma, et al.
Oncotarget|August 16, 2019
Correction: PARP-1 inhibitor modulate β-catenin signaling to enhance cisplatin sensitivity in cancer cervixMinakshi Mann, Sachin Kumar, Shyam S Chauhan, et al.
Journal of the American Heart Association|March 26, 2013
Glycemic associations with endothelial function and biomarkers among 5 ethnic groups: the Multi-Ethnic Study of Atherosclerosis and the Mediators of Atherosclerosis in South Asians Living in America studiesAlka M Kanaya, Devon A Dobrosielski, Peter Ganz, et al.
Clinical Epigenetics|June 3, 2017
Genome-wide DNA methylation profiling integrated with gene expression profiling identifies <i>PAX9</i> as a novel prognostic marker in chronic lymphocytic leukemiaLata Rani, Nitin Mathur, Ritu Gupta, et al.
Current Pharmaceutical Design|May 27, 2024
Diagnosis of the Initial Stage of Hepatocellular Carcinoma: A ReviewKrishana Kumar Sharma, Mohd Mohsin, Piyush Mittal, et al.
Pageof 34